Epilepsy & seizure disorders Board decisions

The Board granted a 100 percent rating for the Veteran's seizure disability beginning February 24, 2024, and SMC at the 's' rate from February 29, 2024.

The Board granted a 100 percent disability rating for the Veteran's psychiatric disorder, finding that his symptoms significantly impaired all areas of life functioning.

The Board denied service connection for peripheral arterial occlusive disease, hypertension, diabetes mellitus type 2, a seizure disorder as secondary to hypertension and/or diabetes mellitus, cataracts as secondary to hypertension and diabetes mellitus, and hyperlipidemia as secondary to hypertension.

The Board remands the claims for an earlier effective date for a 100 percent rating and SMC based on housebound status due to insufficient evidence regarding the severity of the Veteran's condition during the relevant period.

The Board granted an earlier effective date for the Veteran's service-connected bilateral hearing loss and reopened and granted claims for service connection of acquired psychiatric disorder, colon cancer s/p resection, and left knee condition. The claims for tinnitus, epilepsy petit mal, diabetes mellitus Type 2, and cardiomyopathy were denied.

The Board granted a disability rating of 30 percent for cervical strain with degenerative arthritis of the spine, spondylolisthesis and cervical angina but denied service connection for several other conditions including back disability, radiculopathy, shin splints, major depressive disorder, left shoulder disability, seizure disorder, dysthymic disorder, and vision disability.

The Board denied earlier effective dates, increased ratings for the acquired psychiatric disorder, and a total disability rating due to individual unemployability.

The Board denied service connection for residuals of a gunshot wound to the left ankle and remanded claims related to a seizure disorder, migraine headaches, and an acquired psychiatric disorder.

The Board denied service connection for bilateral hearing loss and remanded the claims for right knee condition, seizure disorder due to head injury, and an acquired psychiatric disorder.

The Board remands the claims for service connection for an acquired psychiatric disorder and epilepsy/seizure disorder due to a pre-decisional duty-to-assist error.

The Board granted an effective date of November 22, 2022, for the grant of service connection for tonic-clonic seizures and an initial 40 percent evaluation. Special monthly compensation based on aid and attendance was denied.

The Board granted service connection for the Veteran's focal motor seizures and tremors, which were related to his ACDUTRA service at Camp Lejeune. The claims for malignant degenerative disc disease, systemic sclerosis, and gadolinium-induced nephrogenic systemic are remanded for further examination.

The Board denied the Veteran's claims for earlier effective dates for service connection for TBI, psychomotor epilepsy, and migraines.

The Board denied the veteran's claims for increased ratings for erectile dysfunction, epilepsy, bowel dysfunction, and degenerative joint disease of the lumbar spine with intervertebral disc syndrome.

The Board denied the veteran's claims for earlier effective dates and higher ratings for various service-connected conditions, except for a separate 30% rating for Parkinson's disease with right upper extremity tremor and a separate 20% rating for right lower extremity tremor.

The Board denied the claims for service connection for a seizure disorder, vertigo, and traumatic brain injury as there is no evidence of these conditions during or shortly after service. The claims for bladder incontinence, migraine headaches, and right thumb pain were remanded for further development.

The Board remands the matter for an adequate medical opinion regarding whether the Veteran's service-connected disabilities aggravated any of the conditions that directly caused his death.

The Board remands the matter to obtain a VA medical opinion regarding whether the Veteran's reported fatigue and behavioral changes are related to her seizure medication.

The Board granted an effective date of August 14, 2023, for the grant of a 70 percent disability rating for PTSD but denied earlier effective dates for service connection for psychomotor epilepsy and paroxysmal atrial tachycardia with systolic heart murmur.

The Board denied increased ratings for generalized seizure disorder, chronic sinusitis, deviated nasal septum, and scars, but granted increased ratings of 20 percent for degenerative joint disease in the left and right ankles.